Lee Pharmaceuticals, Inc.
AIMN
$0.01
$0.00-36.36%
OTC PK
| 06/30/2022 | 03/31/2022 | ||||
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 13.20K | -- | |||
| Total Receivables | -- | -- | |||
| Inventory | -- | -- | |||
| Prepaid Expenses | -- | -- | |||
| Finance Division Loans and Leases Current | -- | -- | |||
| Total Finance Division Other Current Assets | -- | -- | |||
| Other Current Assets | -- | -- | |||
| Total Current Assets | 13.20K | -- | |||
|
|
|||||
| Total Current Assets | 13.20K | -- | |||
| Net Property, Plant & Equipment | -- | -- | |||
| Long-term Investments | -- | -- | |||
| Goodwill | -- | -- | |||
| Total Other Intangibles | -- | -- | |||
| Finance Div Loans & Leases LT | -- | -- | |||
| Total Finance Div Other LT Assets | -- | -- | |||
| Total Other Assets | -- | -- | |||
| Total Assets | 13.20K | -- | |||
|
|
|||||
| Total Accounts Payable | -- | -- | |||
| Total Accrued Expenses | -- | -- | |||
| Short-term Debt | 130.70K | -- | |||
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | |||
| Finance Division Debt Current | -- | -- | |||
| Total Finance Division Other Current Liabilities | 424.60K | -- | |||
| Total Other Current Liabilities | 424.60K | -- | |||
| Total Current Liabilities | 555.30K | -- | |||
|
|
|||||
| Total Current Liabilities | 555.30K | -- | |||
| Long-Term Debt | -- | -- | |||
| Short-term Debt | 130.70K | -- | |||
| Capital Leases | -- | -- | |||
| Finance Division Debt Non Current | -- | -- | |||
| Total Finance Division Other Non Current Liabilities | -- | -- | |||
| Total Other Liabilities | -- | -- | |||
| Total Liabilities | 555.30K | -- | |||
|
|
|||||
| Common Stock & APIC | 4.78M | -- | |||
| Retained Earnings | -5.32M | -- | |||
| Treasury Stock & Other | -- | -- | |||
| Total Common Equity | -542.10K | 13.20K | |||
|
|
|||||
| Preferred Stock Redeemable | -- | -- | |||
| Preferred Stock Non Redeemable | -- | -- | |||
| Preferred Stock Convertible | -- | -- | |||
| Preferred Stock, Others | -- | -- | |||
| Total Preferred Equity | -- | -- | |||
|
|
|||||
| Total Common Equity | -542.10K | 13.20K | |||
| Total Preferred Equity | -- | -- | |||
| Total Minority Interest | -- | -- | |||
| Total Equity | -542.10K | 13.20K | |||
|
|
|||||